Cardinal Health Dirección

Dirección controles de criterios 2/4

El CEO de Cardinal Health es Jason Hollar , nombrado en Sep 2022, tiene una permanencia de 2.17 años. compensación anual total es $25.65M, compuesta por 5.6% salario y 94.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.008% de las acciones de la empresa, por valor de €2.04M. La antigüedad media del equipo directivo y de la junta directiva es de 2.2 años y 4.3 años, respectivamente.

Información clave

Jason Hollar

Chief Executive Officer (CEO)

US$25.7m

Compensación total

Porcentaje del salario del CEO	5.6%
Permanencia del CEO	2.2yrs
Participación del CEO	0.008%
Permanencia media de la dirección	2.2yrs
Promedio de permanencia en la Junta Directiva	4.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jason Hollar en comparación con los beneficios de Cardinal Health?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	US$1b
Jun 30 2024	US$26m	US$1m	US$852m
Mar 31 2024	n/a	n/a	US$604m
Dec 31 2023	n/a	n/a	US$691m
Sep 30 2023	n/a	n/a	US$208m
Jun 30 2023	US$19m	US$1m	US$330m
Mar 31 2023	n/a	n/a	US$463m
Dec 31 2022	n/a	n/a	-US$1b
Sep 30 2022	n/a	n/a	-US$1b
Jun 30 2022	US$4m	US$729k	-US$938m
Mar 31 2022	n/a	n/a	-US$955m
Dec 31 2021	n/a	n/a	US$555m
Sep 30 2021	n/a	n/a	US$1b
Jun 30 2021	US$4m	US$700k	US$611m
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	n/a	n/a	US$1b
Sep 30 2020	n/a	n/a	US$973m
Jun 30 2020	US$4m	US$124k	-US$4b

Compensación vs. Mercado: La compensación total de Jason($USD25.65M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD4.87M).

Compensación vs. Ingresos: La compensación de Jason ha aumentado más de un 20% en el último año.

CEO

Jason Hollar (51 yo)

2.2yrs

Permanencia

US$25,650,709

Compensación

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Jason Hollar	CEO & Director	2.2yrs	US$25.65m	0.0075% € 2.0m
Aaron Alt	Chief Financial Officer	1.8yrs	US$6.84m	0.0013% € 340.8k
Jessica Mayer	Chief Legal & Compliance Officer	5.7yrs	US$4.66m	0.011% € 2.9m
Stephen Mason	Chief Executive Officer of Medical Segment	5.3yrs	US$7.34m	0% € 0
Deborah Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment	2.2yrs	US$5.09m	0.0083% € 2.3m
Mary Scherer	Senior VP & Chief Accounting Officer	2.2yrs	sin datos	0.0036% € 979.1k
Michelle Greene	Executive VP	2.3yrs	sin datos	0.0080% € 2.2m
Matt Sims	Vice President of Investor Relations	no data	sin datos	sin datos
Ola Snow	Chief Human Resources Officer	6.1yrs	sin datos	0.011% € 3.1m
Craig Cowman	Executive Vice President of Biopharma Solutions & Strategic Sourcing	no data	sin datos	sin datos
Patricia English	Senior Vice President	1.8yrs	US$1.26m	0.0020% € 551.8k
Ben Brinker	President of Global Products & Supply Chain	3.7yrs	sin datos	sin datos

2.2yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CLH se considera experimentado (2.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Jason Hollar	CEO & Director	2.3yrs	US$25.65m	0.0075% € 2.0m
Gregory Kenny	Independent Non-Executive Chairman	17.3yrs	US$570.10k	0% € 0
Christine Ann Mundkur	Independent Director	2.2yrs	US$318.09k	0% € 0
Patricia Hemingway Hall	Independent Director	11.2yrs	US$338.09k	0.0045% € 1.2m
David Evans	Independent Director	4.3yrs	US$320.09k	0% € 0
Sheri Edison	Independent Director	4.2yrs	US$338.09k	0.0017% € 454.4k
Nancy Killefer	Independent Director	9.2yrs	US$330.61k	0% € 0
Akhil Johri	Independent Director	6.8yrs	US$345.09k	0% € 0
Robert Azelby	Independent Director	less than a year	US$182.66k	0% € 0
Michelle Brennan	Independent Director	2.2yrs	US$318.09k	0.0022% € 592.3k

4.3yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de CLH se considera experimentada (4.3 años de antigüedad promedio).

Cardinal Health Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold €7.2m worth of stock

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Chief Legal & Compliance Officer recently sold €3.2m worth of stock

Recent updates

Cardinal Health, Inc. (NYSE:CAH) entered into definitive agreement to acquire Advanced Diabetes Supply Group from Court Square Capital Management, L.P. for approximately $1.1 billion.

First quarter dividend of US$0.51 announced

First quarter 2025 earnings released: EPS: US$1.71 (vs US$0.02 in 1Q 2024)

Cardinal Health, Inc. to Report Q1, 2025 Results on Nov 01, 2024

Upcoming dividend of US$0.51 per share

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold €7.2m worth of stock

Fourth quarter dividend of US$0.51 announced

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2024

Full year 2024 earnings released: EPS: US$3.48 (vs US$1.00 in FY 2023)

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Cardinal Health, Inc. to Report Q4, 2024 Results on Aug 14, 2024

Third quarter dividend of US$0.51 announced

Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024

Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024

Third quarter 2024 earnings released: EPS: US$1.06 (vs US$1.35 in 3Q 2023)

Cardinal Health, Inc. to Report Q3, 2024 Results on May 02, 2024

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Second quarter dividend of US$0.50 announced

Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024

Second quarter 2024 earnings released: EPS: US$1.44 (vs US$0.50 loss in 2Q 2023)

Cardinal Health, Inc. (NYSE:CAH) entered into a definitive agreement to acquire Specialty Networks, LLC for $1.2 billion.

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.50 per share at 2.0% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2024

Cardinal Health Launches Smartgown™ Edge Breathable Surgical Gown with Assist™ Instrument Pockets

First quarter 2024 earnings released: EPS: US$0.02 (vs US$0.41 in 1Q 2023)

Cardinal Health Launches Kangaroo OMNI Enteral Feeding Pump

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Cardinal Health, Inc. to Report Q1, 2024 Results on Nov 03, 2023

Upcoming dividend of US$0.50 per share at 2.3% yield

Chief Legal & Compliance Officer recently sold €3.2m worth of stock

Cardinal Health, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: EPS: US$1.00 (vs US$3.34 loss in FY 2022)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2023

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Cardinal Health, Inc. to Report Q4, 2023 Results on Aug 15, 2023

Upcoming dividend of US$0.50 per share at 2.2% yield

Cardinal Health, Inc. (NYSE:CAH) announces an Equity Buyback for $3,500 million worth of its shares.

Transaction Data Systems, Inc. agreed to acquire Outcomes business of Cardinal Health.

Cardinal Health Launches Modern Commerce Solutions for Retail Independent Pharmacies Powered by Square

Now 20% undervalued

Cardinal Health, Inc. Announces Quarterly Dividend, Payable on July 15, 2023

Third quarter 2023 earnings released: EPS: US$1.35 (vs US$5.06 loss in 3Q 2022)

Upcoming dividend of US$0.50 per share at 2.9% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on April 15, 2023

Cardinal Health, Inc. Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings released: US$0.50 loss per share (vs US$0.18 profit in 2Q 2022)

Cardinal Health, Inc. to Report Q2, 2023 Results on Feb 02, 2023

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc Announces Executive Changes, Effective February 10, 2023

Insider recently sold €3.6m worth of stock

Cardinal Health Announces the Launch of Velocare

Insider recently sold €3.6m worth of stock

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2023

First quarter 2023 earnings released

Cardinal Health, Inc., Annual General Meeting, Nov 09, 2022

Cardinal Health, Inc. to Report Q1, 2023 Results on Nov 04, 2022

Upcoming dividend of US$0.50 per share

Cardinal Health Announces Executive Changes

Cardinal Health, Inc. Announces Executive Appointments

High number of new directors

Full year 2022 earnings released: US$3.34 loss per share (vs US$2.09 profit in FY 2021)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2022

Cardinal Health Appoints Michelle Greene as Chief Information Officer

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.